Chatzistamou I - Search Results

1

Expression of p21waf1/Cip1 in stromal fibroblasts of primary breast tumors.

Trimis G, Chatzistamou I, Politi K, Kiaris H, Papavassiliou AG. Trimis G, et al. Among authors: chatzistamou i. Hum Mol Genet. 2008 Nov 15;17(22):3596-600. doi: 10.1093/hmg/ddn252. Epub 2008 Aug 18. Hum Mol Genet. 2008. PMID: 18713757

2

Toxic PARP trapping upon cAMP-induced DNA damage reinstates the efficacy of endocrine therapy and CDK4/6 inhibitors in treatment-refractory ER+ breast cancer.

Saatci O, Cetin M, Uner M, Tokat UM, Chatzistamou I, Ersan PG, Montaudon E, Akyol A, Aksoy S, Uner A, Marangoni E, Sajish M, Sahin O. Saatci O, et al. Among authors: chatzistamou i. Nat Commun. 2023 Nov 2;14(1):6997. doi: 10.1038/s41467-023-42736-y. Nat Commun. 2023. PMID: 37914699 Free PMC article.

3

Expression of growth hormone-releasing hormone in human primary endometrial carcinomas.

Chatzistamou I, Schally AV, Pafiti A, Kiaris H, Koutselini H. Chatzistamou I, et al. Eur J Endocrinol. 2002 Sep;147(3):381-6. doi: 10.1530/eje.0.1470381. Eur J Endocrinol. 2002. PMID: 12213676

4

Ligand-dependent and -independent effects of splice variant 1 of growth hormone-releasing hormone receptor.

Kiaris H, Chatzistamou I, Schally AV, Halmos G, Varga JL, Koutselini H, Kalofoutis A. Kiaris H, et al. Among authors: chatzistamou i. Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9512-7. doi: 10.1073/pnas.1533185100. Epub 2003 Jul 16. Proc Natl Acad Sci U S A. 2003. PMID: 12867592 Free PMC article.

5

Tumour-stroma interactions in carcinogenesis: basic aspects and perspectives.

Kiaris H, Chatzistamou I, Kalofoutis Ch, Koutselini H, Piperi Ch, Kalofoutis A. Kiaris H, et al. Among authors: chatzistamou i. Mol Cell Biochem. 2004 Jun;261(1-2):117-22. doi: 10.1023/b:mcbi.0000028746.54447.6c. Mol Cell Biochem. 2004. PMID: 15362494 Review.

6

Immunohistochemical detection of GHRH and its receptor splice variant 1 in primary human breast cancers.

Chatzistamou I, Schally AV, Kiaris H, Politi E, Varga J, Kanellis G, Kalofoutis A, Pafiti A, Koutselini H. Chatzistamou I, et al. Eur J Endocrinol. 2004 Sep;151(3):391-6. doi: 10.1530/eje.0.1510391. Eur J Endocrinol. 2004. PMID: 15362970

7

Evidence for nonautonomous effect of p53 tumor suppressor in carcinogenesis.

Kiaris H, Chatzistamou I, Trimis G, Frangou-Plemmenou M, Pafiti-Kondi A, Kalofoutis A. Kiaris H, et al. Among authors: chatzistamou i. Cancer Res. 2005 Mar 1;65(5):1627-30. doi: 10.1158/0008-5472.CAN-04-3791. Cancer Res. 2005. PMID: 15753354

8

Expression of growth hormone-releasing hormone (GHRH) and splice variant of GHRH receptors in normal mouse tissues.

Christodoulou C, Schally AV, Chatzistamou I, Kondi-Pafiti A, Lamnissou K, Kouloheri S, Kalofoutis A, Kiaris H. Christodoulou C, et al. Among authors: chatzistamou i. Regul Pept. 2006 Sep 11;136(1-3):105-8. doi: 10.1016/j.regpep.2006.05.001. Epub 2006 Jun 16. Regul Pept. 2006. PMID: 16781787

9

Expression of ERp29, an endoplasmic reticulum secretion factor in basal-cell carcinoma.

Cheretis C, Dietrich F, Chatzistamou I, Politi K, Angelidou E, Kiaris H, Mkrtchian S, Koutselini H. Cheretis C, et al. Among authors: chatzistamou i. Am J Dermatopathol. 2006 Oct;28(5):410-2. doi: 10.1097/01.dad.0000211521.49810.ac. Am J Dermatopathol. 2006. PMID: 17012915

10

Expression of growth hormone-releasing hormone receptor splice variant 1 in primary human melanomas.

Chatzistamou I, Volakaki AA, Schally AV, Kiaris H, Kittas C. Chatzistamou I, et al. Regul Pept. 2008 Apr 10;147(1-3):33-6. doi: 10.1016/j.regpep.2007.12.008. Epub 2008 Jan 11. Regul Pept. 2008. PMID: 18255167

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

100 results

Search Page

Filters